Ultra-high Frequency Ultrasound Technology Available for Preclinical Research The Vevo imaging platform was the world’s first commercially available ultra-high frequency array-based ultrasound imaging system and has since emerged as the gold standard in …

Our unique photoacoustic Imaging technology is an  in vivo hybrid imaging modality. Photoacoustics combines the sensitivity and contrast of optical imaging with the depth and high resolution of our ultrasound technology. When pulsed laser light …

As we continue to develop new products and improve our technology, we sometimes find it necessary to retire products. In order to help you plan ahead and manage your equipment, retired products with their related dates and documentation are outlined …

Presented by:  Jonathan Lavaud from Plateforme OPTIMAL, Institute for Advanced Bioscience In this webinar: Whole body photoacoustic imaging with the Vevo LAZR-X imaging system through extended cross sectional 3D imaging Use of epi- and trans-illumination …

FUJILFILM VisualSonics, Inc.   VisualSonics is a rapidly growing biomedical company and the world leader in developing high-resolution ultrasound devices for small animal research. VisualSonics offers a pleasant and progressive work environment with a …

AIMS: The incidence and mortality of myocardial infarction (MI) in diabetic patients are higher than in non-diabetic patients; however, the mechanisms by which diabetes results in cardiac dysfunction are poorly understood. The present study tested the …

BACKGROUND: Diabetes is associated with an increased risk of cardiac microvascular disease. The mechanisms by which this damage occurs are unknown. However, research suggests that signaling through the sphingosine-1-phosphates receptor 1 and 3 (S1P1/3) by …

Preconception or gestationally induced diabetes increases morbidities and elevates long-term cardiovascular disease risks in women and their children. Spontaneously hyperglycemic (d)-NOD/ShiLtJ female mice, a type 1 diabetes model, develop bradycardia and …